Sulfuric Acid

Sulfuric Acid

SCHEMBL481202

O=S(=O)([O-])[O-].O=S(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+]

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.60
TSHR P16473 2/20 0.60
MEN1 O00255 1/20 0.60
KMT2A Q03164 1/20 0.60
TP53 P04637 2/20 0.40
KDM4E B2RXH2 2/20 0.38
MAPT P10636 1/20 0.38
ALOX15 P16050 1/20 0.38
GMNN O75496 1/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33
THPO P40225 1/20 0.33
HBB P68871 1/20 0.33
PMP22 Q01453 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CA5A P35218 2/20 0.30
CA5B Q9Y2D0 2/20 0.30
CYP3A4 P08684 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL29020604 1.00 ALDH1A1 (0.60) ALDH1A1TSHRMEN1KMT2ATP53
Sulfuric Acid SCHEMBL1420915 1.00 ALDH1A1 (0.60) ALDH1A1TSHRMEN1KMT2ATP53
Sulfuric Acid SCHEMBL7891773 1.00 ALDH1A1 (0.60) ALDH1A1TSHRMEN1KMT2ATP53
Sulfuric Acid SCHEMBL7334619 1.00 ALDH1A1 (0.60) ALDH1A1TSHRMEN1KMT2ATP53
Sulfuric Acid SCHEMBL412 1.00
Sulfuric Acid SCHEMBL8732464 1.00 ALDH1A1 (0.60) ALDH1A1TSHRMEN1KMT2ATP53
Sulfuric Acid SCHEMBL11430373 1.00 ALDH1A1 (0.60) ALDH1A1TSHRMEN1KMT2ATP53
Sulfuric Acid SCHEMBL29132022 1.00 ALDH1A1 (0.60) ALDH1A1TSHRMEN1KMT2ATP53
Sulfuric Acid SCHEMBL62673 0.94 ALDH1A1 (0.55) ALDH1A1TSHRMEN1KMT2ATP53
Sulfuric Acid SCHEMBL2542518 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12584926-B2 Methods for identifying haemoglobin S or C in a biological sample and kits thereof INDIAN INSTITUTE OF SCIENCE (IN) 2026-03-24 US claimed
CN-120137430-A Technology of pure inorganic multifunctional mineral paint 四川裕霖环境工程有限公司 2025-06-13 CN claimed
CN-114381734-B Etching solution composition for etching copper double-layer metal wiring structure, preparation method, application and method for manufacturing thin film array substrate 达高工业技术研究院(广州)有限公司 2022-09-27 CN claimed
US-20220283188-A1 Methods for Identifying Haemoglobin S or C in a Biological Sample and Kits Thereof INDIAN INSTITUTE OF SCIENCE (IN) 2022-09-08 US claimed
CN-114411136-A Device and method for smearing and repairing phosphate conversion film 东北大学 2022-04-29 CN claimed
CN-114381734-A Etching solution composition for etching copper double-layer metal wiring structure, preparation method, application and method for manufacturing thin film array substrate 达高工业技术研究院(广州)有限公司 2022-04-22 CN claimed
CN-109825866-B Preparation method of alloy self-repairing corrosion-resistant micro-arc oxidation coating 东北大学 2020-11-27 CN claimed
US-12584926-B2 Methods for identifying haemoglobin S or C in a biological sample and kits thereof INDIAN INSTITUTE OF SCIENCE (IN) 2026-03-24 US disclosed
EP-4687843-A1 FORMULATIONS AND USES THEREOF Sartorius Albumedix Limited (GB) 2026-02-11 EP disclosed
CN-120137430-A Technology of pure inorganic multifunctional mineral paint 四川裕霖环境工程有限公司 2025-06-13 CN disclosed
WO-2024209085-A1 FORMULATIONS AND USES THEREOF ALBUMEDIX LTD (GB) 2024-10-10 WO disclosed
US-12087564-B2 Tuned synthetic dendrimer calibrants for mass spectrometry THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2024-09-10 US disclosed
US-20240199581-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF C4 THERAPEUTICS, INC. (US) 2024-06-20 US disclosed
EP-1618121-A1 PROCESS FOR PREPARING URSODEOXYCHOLIC ACID DI-SODIUM 3,7-DISULFATE ERREGIERRE S.p.A. (IT) 2006-01-25 EP disclosed
EP-1582219-A1 CONNEXIN 26 INHIBITORS AND CANCER METASTASIS INHIBITORS Japan Science and Technology Agency (JP) 2005-10-05 EP disclosed
WO-2004092193-A1 PROCESS FOR PREPARING URSODEOXYCHOLIC ACID DI-SODIUM 3,7-DISULFATE ERREGIERRE S.P.A. (IT) 2004-10-28 WO disclosed
EP-0717645-A1 REDUCTION OF SKIN IRRITATION AND RESISTANCE DURING ELECTROTRANSPORT ALZA CORPORATION (US) 1996-06-26 EP disclosed
WO-1995006497-A1 REDUCTION OF SKIN IRRITATION AND RESISTANCE DURING ELECTROTRANSPORT ALZA CORPORATION (US) 1995-03-09 WO disclosed
EP-0369337-A1 Cellulose aminomethanate sausage casings Teepak, Inc. (US) 1990-05-23 EP disclosed
US-4818671-A CONTAINING GOLD COMPOUND, SULFUR SENSITIZER, CYANINE DYE KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1989-04-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240199581-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF BRAF, NRAS, KRAS ALDH1A1 1471/4885TSHR 1660/4885MEN1 594/4885
US-12584926-B2 Methods for identifying haemoglobin S or C in a biological sample and kits thereof HBB, HBG1, HBG2 ALDH1A1 1672/4885TSHR 3268/4885MEN1 4538/4885
US-12087564-B2 Tuned synthetic dendrimer calibrants for mass spectrometry SRMS, SRM, DNMT1 ALDH1A1 3381/4885TSHR 2889/4885MEN1 277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.